Literature DB >> 7604021

The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice.

R L Ferrero1, J M Thiberge, I Kansau, N Wuscher, M Huerre, A Labigne.   

Abstract

Helicobacter pylori is an important etiologic agent of gastroduodenal disease. In common with other organisms, H. pylori bacteria express heat shock proteins that share homologies with the GroES-GroEL class of proteins from Escherichia coli. We have assessed the heat shock proteins of H. pylori as potential protective antigens in a murine model of gastric Helicobacter infection. Orogastric immunization of mice with recombinant H. pylori GroES- and GroEL-like proteins protected 80% (n = 20) and 70% (n = 10) of animals, respectively, from a challenge dose of 10(4) Helicobacter felis bacteria (compared to control mice, P = 0.0042 and P = 0.0904, respectively). All mice (n = 19) that were immunized with a dual antigen preparation, consisting of H. pylori GroES-like protein and the B subunit of H. pylori urease, were protected against infection. This represented a level of protection equivalent to that provided by a sonicated Helicobacter extract (P = 0.955). Antibodies directed against the recombinant H. pylori antigens were predominantly of the IgG1 class, suggesting that a type 2 T-helper cell response was involved in protection. This work reports a protein belonging to the GroES class of heat shock proteins that was shown to induce protective immunity. In conclusion, GroES-like and urease B-subunit proteins have been identified as potential components of a future H. pylori subunit vaccine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7604021      PMCID: PMC41545          DOI: 10.1073/pnas.92.14.6499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  Mucosal immunity to infection with implications for vaccine development.

Authors:  H F Staats; R J Jackson; M Marinaro; I Takahashi; H Kiyono; J R McGhee
Journal:  Curr Opin Immunol       Date:  1994-08       Impact factor: 7.486

2.  Humoral and cellular immune recognition of Helicobacter pylori proteins are not concordant.

Authors:  S A Sharma; G G Miller; G I Perez-Perez; R S Gupta; M J Blaser
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

3.  Humoral, mucosal, and cellular immune response to topical immunization with a subunit respiratory syncytial virus vaccine.

Authors:  E E Walsh
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

4.  Molecular analysis of urease genes from a newly identified uncultured species of Helicobacter.

Authors:  J V Solnick; J O'Rourke; A Lee; L S Tompkins
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection.

Authors:  R L Ferrero; J M Thiberge; M Huerre; A Labigne
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

6.  Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease.

Authors:  P Michetti; I Corthésy-Theulaz; C Davin; R Haas; A C Vaney; M Heitz; J Bille; J P Kraehenbuhl; E Saraga; A L Blum
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

7.  Immunisation against gastric infection with Helicobacter species: first step in the prophylaxis of gastric cancer?

Authors:  M Chen; A Lee; S Hazell; P Hu; Y Li
Journal:  Zentralbl Bakteriol       Date:  1993-09

8.  Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH.

Authors:  A Morris; G Nicholson
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

9.  Hepatitis A and evidence against the community dissemination of Helicobacter pylori via feces.

Authors:  S L Hazell; H M Mitchell; M Hedges; X Shi; P J Hu; Y Y Li; A Lee; E Reiss-Levy
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

10.  Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori.

Authors:  K A Eaton; S Krakowka
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more
  71 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Selective T-cell recognition of the N-terminal peptide of GroES in tuberculosis.

Authors:  Boosbun Chua-Intra; Robert J Wilkinson; Juraj Ivanyi
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

3.  T-cell, antibody, and cytokine responses to homologs of the 60-kilodalton heat shock protein in Helicobacter pylori infection.

Authors:  S A Sharma; G G Miller; R A Peek; G Pérez-Pérez; M J Blaser
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

4.  Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice.

Authors:  T Goto; A Nishizono; T Fujioka; J Ikewaki; K Mifune; M Nasu
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Assessment of Helicobacter pylori gene expression within mouse and human gastric mucosae by real-time reverse transcriptase PCR.

Authors:  B Rokbi; D Seguin; B Guy; V Mazarin; E Vidor; F Mion; M Cadoz; M J Quentin-Millet
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies.

Authors:  B Kimmel; A Bosserhoff; R Frank; R Gross; W Goebel; D Beier
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

7.  Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa.

Authors:  H A Haeberle; M Kubin; K B Bamford; R Garofalo; D Y Graham; F El-Zaatari; R Karttunen; S E Crowe; V E Reyes; P B Ernst
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

8.  Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.

Authors:  Sekar Tamil Selvi Chitradevi; Gurpreet Kaur; Sivaramakrishna Uppalapati; Anandprakash Yadav; Dependrapratap Singh; Anju Bansal
Journal:  Cell Mol Immunol       Date:  2015-02-02       Impact factor: 11.530

9.  Analysis of immune responses against H pylori in rabbits.

Authors:  Khademul Islam; Ibrahim Khalil; Chowdhury Rafiqul Ahsan; Mahmuda Yasmin; Jamalun Nessa
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

10.  Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection.

Authors:  Ji-Hyun Shin; Mierha Yang; Seung Woo Nam; Jung Taik Kim; Na Hye Myung; Won-Gi Bang; Im Hwan Roe
Journal:  Clin Diagn Lab Immunol       Date:  2002-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.